캐피털포스 ETF 트러스트 - 캡포스 IBD 50 ETF
US ˙ ARCA

SecurityFFTY / Capital-Force ETF Trust - CapForce IBD 50 ETF
InstitutionIFP Advisors, Inc
Latest Disclosed Ownership54 shares
Latest Disclosed Value $ 1,804
IFP Advisors, Inc reports 3.57% decrease in ownership of FFTY / Capital-Force ETF Trust - CapForce IBD 50 ETF

On April 13, 2026 - IFP Advisors, Inc filed a 13F-HR form disclosing ownership of 54 shares of Capital-Force ETF Trust - CapForce IBD 50 ETF (US:FFTY) valued at $1,804 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 56 shares of Capital-Force ETF Trust - CapForce IBD 50 ETF. This represents a change in shares of -3.57% during the quarter. The current value of the position is $2,284 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F INNOVATOR ETFS TRUST mc 45782C102 54 -2 -3.57 2 0.00 0.0000
2026-02-06 2025-12-31 13F INNOVATOR ETFS TRUST mc 45782C102 56 3 5.66 2 0.00 0.0000
2026-02-06 2025-09-30 13F/A-1 INNOVATOR ETFS TRUST IBD 50 ETF mc 45782C102 53 0 0.00 2 0.00 0.0001
2025-12-02 2025-09-30 13F INNOVATOR ETFS TRUST IBD 50 ETF mc 45782C102 53 0 2 0.0001
2025-07-24 2025-06-30 13F INNOVATOR ETFS TRUST IBD mc 45782C102 53 53 2 0.0000
2024-01-09 2023-12-31 13F INNOVATOR ETFS TR mc 45782C102 0 -135 -100.00 0 -100.00
2023-10-12 2023-09-30 13F INNOVATOR ETFS TR mc 45782C102 135 0 0.00 3 0.00 0.0001
2023-08-14 2023-06-30 13F/A-1 INNOVATOR ETFS TR mc 45782C102 135 -150 -52.63 3 -66.67 0.0001
2023-08-04 2023-06-30 13F INNOVATOR ETFS TR mc 45782C102 135 -150 5 0.0002
2023-04-18 2023-03-31 13F INNOVATOR ETFS TR mc 45782C102 285 10 3.64 10 0.0004
2023-02-07 2022-12-31 13F INNOVATOR ETFS TR mc 45782C102 275 0 0.00 0 -100.00 0.0002
2022-11-08 2022-09-30 13F INNOVATOR ETFS TR mc 45782C102 275 0 0.00 9 0.00 0.0002
2022-09-06 2022-06-30 13F/A-1 INNOVATOR ETFS TR mc 45782C102 275 0 0.00 9 0.00 0.0003
2022-09-06 2022-03-31 13F/A-1 INNOVATOR ETFS TR mc 45782C102 275 100 57.14 9 12.50 0.0003
2022-08-08 2022-03-31 13F INNOVATOR ETFS TR IBD 50 ETF CEF 45782C102 175 0 6 0.0001
2022-01-12 2021-12-31 13F INNOVATOR ETFS TR IBD 50 ETF CEF 45782C102 175 0 0.00 8 0.00 0.0002
2021-10-06 2021-09-30 13F INNOVATOR ETFS TR IBD 50 ETF CEF 45782C102 175 0 0.00 8 0.00 0.0002
2021-07-13 2021-06-30 13F INNOVATOR ETFS TR IBD 50 ETF CEF 45782C102 175 0 0.00 8 0.00 0.0002
2021-04-30 2021-03-31 13F INNOVATOR ETFS TR IBD 50 ETF CEF 45782C102 175 -431 -71.12 8 -66.67 0.0002
2021-01-25 2020-12-31 13F INNOVATOR ETFS TR IBD 50 ETF CEF 45782C102 606 -300 -33.11 24 -29.41 0.0010
2020-10-29 2020-09-30 13F INNOVATOR ETFS TR IBD 50 ETF CEF 45782C102 906 400 79.05 34 100.00 0.0020
2020-08-05 2020-06-30 13F INNOVATOR ETFS TR IBD 50 ETF CEF 45782C102 506 231 84.00 17 112.50 0.0013
2020-05-12 2020-03-31 13F INNOVATOR ETFS TR IBD 50 ETF CEF 45782C102 275 -40 -12.70 8 -20.00 0.0008
2020-01-17 2019-12-31 13F INNOVATOR ETFS TR IBD 50 ETF CEF 45782C102 315 -10,385 -97.06 10 -97.09 0.0008
2019-11-07 2019-09-30 13F INNOVATOR ETFS TR IBD 50 ETF CEF 45782C102 10,700 -33,442 -75.76 344 -76.71 0.0230
2019-05-15 2019-03-31 13F INNOVATORIBD 50 ETF ETF 45782C102 44,142 -3,602 -7.54 1,477 13.18 0.2017
2019-06-03 2018-12-31 13F/A-10 INNOVATOR IBD 50 ETF ETF 45782C102 47,744 -26,815 -35.96 1,305 -54.47 0.0795
2019-01-23 2018-12-31 13F INNOVATOR IBD 50 ETF ETF 45782C102 47,744 -26,815 1,305 0.0795
2019-06-03 2018-09-30 13F/A-9 INNOVATOR IBD 50 ETF ETF 45782C102 74,559 23,792 46.87 2,866 60.83 0.1168
2018-10-25 2018-09-30 13F INNOVATOR IBD 50 ETF ETF 45782C102 74,559 23,792 2,866 0.1168
2019-06-03 2018-06-30 13F/A-8 INNOVATOR IBD 50 ETF ETF 45782C102 50,767 46,189 1,008.93 1,782 1,072.37 0.0749
2018-08-07 2018-06-30 13F INNOVATOR IBD 50 ETF ETF 45782C102 50,767 36,524 1,782
2019-06-03 2018-03-31 13F/A-7 INNOVATOR IBD 50 ETF ETF 45782C102 4,578 0 0.00 152 0.00 0.0069
2018-05-09 2018-03-31 13F INNOVATOR IBD 50 ETF ETF 45782C102 14,243 9,665 475
2019-06-03 2017-12-31 13F/A-6 INNOVATOR IBD 50 ETF ETF 45782C102 4,578 4,578 -89.63 152 -89.71 0.0069
2018-01-24 2017-12-31 13F INNOVATOR IBD 50 ETF ETF 45782C102 4,578 -39,564 152
2016-08-22 2016-06-30 13F INNOVATORIBD 50 ETF ETF 45782C102 0 -44,142 -100.00 0 -100.00
2019-06-03 2016-03-31 13F/A-1 INNOVATORIBD 50 ETF ETF 45782C102 44,142 44,142 1,477 0.2017
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.